Discovery of Bavachin as a Dual Trk-A/Trk-B Agonist via Integrated Computational Screening and Experimental Validation
Sachin P. Patil, Bella R. Kuehn, Ryan Schlosser, John Samohod
This study identifies Bavachin as a dual Trk-A/Trk-B agonist using computational screening and experimental validation for neurodegenerative disease therapeutics.
bioRxiv · Sep 16, 2026 · PreprintNeuroscience